Autism Spectrum Disorder Screening at 18-36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is

Birol Karabulut1, Begum Sahbudak1

  • 1Karabulut, Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Pediatrics, Division of Neonatology, Izmir, Turkey. Sahbudak, Izmir Katip Celebi University Ataturk Training and Research Hospital, Department of Child and Adolescent Psychiatry.

Insights

Neonatal Encephalopathy (NE) increases the risk of Autism Spectrum Disorder (ASD). This study found a higher incidence of ASD in infants with moderate to severe NE, highlighting the need for long-term follow-up.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Neonatology

Background:

  • Hypoxia, acidosis, and inflammation during infancy can impair neuronal development.
  • Neonatal Encephalopathy (NE) is associated with an increased risk of Autism Spectrum Disorder (ASD).

Purpose of the Study:

  • To determine the frequency of ASD in infants diagnosed with moderate to severe NE who underwent therapeutic hypothermia.
  • To assess the long-term neurodevelopmental outcomes in NE survivors.

Main Methods:

  • A prospective study included infants with moderate and severe NE requiring therapeutic hypothermia.
  • Autism Spectrum Disorder (ASD) screening was performed using the M-CHAT at 18-36 months of age.
  • Infants with positive M-CHAT results underwent psychiatric examinations for diagnosis.

Main Results:

  • Out of 85 NE infants, 33 were included in the study.
  • M-CHAT screening was positive in 6 infants and negative in 27.
  • One infant was diagnosed with ASD, one with ADHD, and two with no psychiatric disorder after clinical examination.

Conclusions:

  • The study indicates an elevated risk of ASD in infants with moderate and severe NE.
  • This association warrants consideration in the long-term clinical management and follow-up of NE patients.
Abstract

Related Concept Videos